← All Sponsors
SPONSOR

Beijing StoneWise Technology Co., Ltd

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Solid Tumor Malignancies
NCT07363967 Phase 1
Recruiting

A Phase I First-in-Human Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of SWA1211 Tablets in Subjects With Advanced Solid Tumors

Solid Tumor Malignancies
China View Trial →